Charles River Laboratories International Inc. (CRL) Social Stream
CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CRL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 9 | $465 | $324 | $418 | $197.1 | 112.08% |
| 2021-11-16 | 9 | $465 | $324 | $424.111 | $197.1 | 115.18% |
| 2022-01-20 | 8 | $465 | $324 | $424.111 | $197.1 | 115.18% |
| 2022-03-15 | 9 | $465 | $324 | $396.555 | $197.1 | 101.19% |
| 2022-04-06 | 9 | $465 | $350 | $405.625 | $197.1 | 105.8% |
| 2022-04-13 | 10 | $465 | $350 | $402.444 | $197.1 | 104.18% |
| 2022-04-25 | 10 | $465 | $280 | $392.444 | $197.1 | 99.11% |
| 2022-05-10 | 10 | $465 | $280 | $359.111 | $197.1 | 82.2% |
| 2022-06-09 | 11 | $465 | $280 | $351.666 | $197.1 | 78.42% |
| 2022-07-19 | 11 | $465 | $255 | $340.555 | $197.1 | 72.78% |
| 2022-07-27 | 11 | $465 | $255 | $338.333 | $197.1 | 71.66% |
| 2022-08-01 | 10 | $465 | $255 | $342.5 | $197.1 | 73.77% |
| 2022-08-05 | 10 | $465 | $230 | $310.625 | $197.1 | 57.6% |
| 2022-08-13 | 10 | $465 | $230 | $308.125 | $197.1 | 56.33% |
| 2022-08-16 | 11 | $400 | $230 | $287.5 | $197.1 | 45.87% |
| 2022-09-17 | 10 | $400 | $230 | $286.25 | $197.1 | 45.23% |
| 2022-10-17 | 10 | $400 | $240 | $287.5 | $197.1 | 45.87% |
| 2022-11-01 | 10 | $400 | $240 | $286.25 | $197.1 | 45.23% |
| 2022-11-03 | 10 | $400 | $240 | $282 | $197.1 | 43.07% |
| 2023-01-11 | 10 | $400 | $241 | $283.25 | $197.1 | 43.71% |
| 2023-01-27 | 11 | $400 | $233 | $281.555 | $197.1 | 42.85% |
| 2023-02-08 | 10 | $300 | $233 | $266.125 | $197.1 | 35.02% |
| 2023-03-01 | 11 | $300 | $230 | $259.8 | $197.1 | 31.81% |
| 2023-04-10 | 11 | $300 | $203 | $256.8 | $197.1 | 30.29% |
| 2023-05-11 | 11 | $300 | $203 | $255.3 | $197.1 | 29.53% |
| 2023-05-12 | 11 | $285 | $205 | $252.5 | $197.1 | 28.11% |
| 2023-06-06 | 11 | $285 | $205 | $249 | $197.1 | 26.33% |
| 2023-07-10 | 11 | $285 | $205 | $245.5 | $197.1 | 24.56% |
| 2023-08-09 | 11 | $285 | $205 | $244.5 | $197.1 | 24.05% |
| 2023-08-11 | 11 | $285 | $207 | $246.7 | $197.1 | 25.16% |
| 2023-09-12 | 11 | $285 | $207 | $249.2 | $197.1 | 26.43% |
| 2023-09-13 | 12 | $285 | $207 | $249.2 | $197.1 | 26.43% |
| 2023-09-20 | 12 | $285 | $207 | $245.818 | $197.1 | 24.72% |
| 2023-09-22 | 12 | $285 | $207 | $244.909 | $197.1 | 24.26% |
| 2023-09-25 | 12 | $285 | $207 | $244.454 | $197.1 | 24.03% |
| 2023-09-26 | 12 | $275 | $207 | $238.363 | $197.1 | 20.94% |
| 2023-10-13 | 12 | $275 | $207 | $237.09 | $197.1 | 20.29% |
| 2023-10-24 | 12 | $275 | $207 | $236.083 | $197.1 | 19.78% |
| 2023-11-08 | 12 | $275 | $207 | $234.833 | $197.1 | 19.14% |
| 2023-11-10 | 13 | $275 | $190 | $227.25 | $197.1 | 15.3% |
| 2023-11-13 | 13 | $275 | $189 | $222.538 | $197.1 | 12.91% |
| 2023-11-28 | 13 | $260 | $189 | $218.692 | $197.1 | 10.95% |
The Trend in the Analyst Price Target
CRL's average price target has moved up $39.89 over the prior 43 months.
CRL reports an average of 21.85% for its upside potential over the past 52 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-15 | 11 | 285 | 205 | 249.000 | 192.36 | 29.44% |
| 2023-06-06 | 11 | 285 | 205 | 249.000 | 201.58 | 23.52% |
| 2023-08-04 | 11 | 285 | 205 | 244.500 | 206.90 | 18.17% |
| 2023-11-07 | 12 | 275 | 207 | 234.833 | 182.81 | 28.46% |
| 2023-11-10 | 13 | 275 | 190 | 227.250 | 171.99 | 32.13% |
CRL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.62 | 9 | 0 | 4 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
CRL's average broker recommendation rating worsened by 0.51 over the prior 19 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRL as an investment opportunity.
- In the context of all US stocks, CHARLES RIVER LABORATORIES INTERNATIONAL INC's average analyst price target is higher than 4698.8% of them.
- CRL has a lower variance in analysts' estimates than -2238.86% of stocks in the large market cap category.
- In the context of stocks in the large market cap category, CHARLES RIVER LABORATORIES INTERNATIONAL INC's upside potential (average analyst target price relative to current price) is greater than 3429.72% of them.
- In terms of how CHARLES RIVER LABORATORIES INTERNATIONAL INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 3467.24% of that group.
Stocks similar to CHARLES RIVER LABORATORIES INTERNATIONAL INC in the Business Services industry regarding analyst recommendations and price targets are INCY, WSC, and ALLE.
View All Top Stocks by Price Target
Is CRL a Buy, Hold or Sell? See the POWR Ratings now!